Unknown

Dataset Information

0

Myeloid-derived macrophages and secreted HSP90? induce pancreatic ductal adenocarcinoma development.


ABSTRACT: We detected a significant elevation of serum HSP90? levels in pancreatitis patients and even more in pancreatic ductal adenocarcinoma (PDAC) patients. However, there was no significant difference in the serum HSP90? levels between patients with early-stage and late-stage PDAC. To study whether elevation of serum HSP90? levels occurred early during PDAC development, we used LSL-KrasG12D/Pdx1-Cre transgenic mice as a studying model. Elevated serum HSP90? levels were detected before PDAC formation and an extracellular HSP90? (eHSP90?) inhibitor effectively prevented PDAC development. Both serum HSP90? level and pancreatic lesion were suppressed when the mice were administered a CD11b-antagonizing antibody, suggesting that CD11b+-myeloid cells were associated with eHSP90? levels and pancreatic carcinogenesis. Consistently, in CD11b-DTR-EGFP transgenic mouse model with CD11b+-myeloid cells depletion, serum HSP90? levels were suppressed and Panc-02 cell grafts failed to develop tumors. Macrophages and granulocytes are two common tissue-infiltrating CD11b+-myeloid cells. Duplex in situ hybridization assays suggested that macrophages were predominant HSP90?-expressing CD11b+-myeloid cells during PDAC development. Immunohistochemical and immunohistofluorescent staining results revealed that HSP90?-expressing cells included not only macrophages but also pancreatic ductal epithelial (PDE) cells. Cell culture studies also indicated that eHSP90? could be produced by macrophages and macrophage-stimulated PDE cells. Macrophages not only secreted significant amount of HSP90?, but also secreted interleukin-6 and interleukin-8 to induce a JAK2-STAT3 signaling axis in PDE cells, stimulating them to express and secrete HSP90?. eHSP90? further promoted cellular epithelial-mesenchymal transition, migration, and invasion in PDE cells. Besides myeloid cells, eHSP90? can be potentially taken as a target to suppress PDAC pathogenesis.

SUBMITTER: Chen CC 

PROVIDER: S-EPMC5927518 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Myeloid-derived macrophages and secreted HSP90α induce pancreatic ductal adenocarcinoma development.

Chen Chia-Chi CC   Chen Li-Li LL   Li Chung-Pin CP   Hsu Yu-Ting YT   Jiang Shih-Sheng SS   Fan Chi-Shuan CS   Chua Kee Voon KV   Huang Sheng-Xiang SX   Shyr Yi-Ming YM   Chen Li-Tzong LT   Huang Tze-Sing TS  

Oncoimmunology 20180201 5


We detected a significant elevation of serum HSP90α levels in pancreatitis patients and even more in pancreatic ductal adenocarcinoma (PDAC) patients. However, there was no significant difference in the serum HSP90α levels between patients with early-stage and late-stage PDAC. To study whether elevation of serum HSP90α levels occurred early during PDAC development, we used LSL-KrasG12D/Pdx1-Cre transgenic mice as a studying model. Elevated serum HSP90α levels were detected before PDAC formation  ...[more]

Similar Datasets

| S-EPMC4912945 | biostudies-literature
| S-EPMC4659838 | biostudies-other
| S-EPMC8231859 | biostudies-literature
| S-EPMC8557582 | biostudies-literature